{"id":4514,"date":"2025-02-21T21:56:38","date_gmt":"2025-02-21T20:56:38","guid":{"rendered":"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/"},"modified":"2025-02-21T21:56:39","modified_gmt":"2025-02-21T20:56:39","slug":"certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc","status":"publish","type":"post","link":"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/","title":{"rendered":"Certains m\u00e9dicaments hypoth\u00e9caires associ\u00e9s \u00e0 un risque plus faible d&rsquo;exacerbations de la MPOC"},"content":{"rendered":"<div>\n<div class=\"article-gallery lightGallery\">\n<div data-thumb=\"https:\/\/scx1.b-cdn.net\/csz\/news\/tmb\/2025\/certain-glucose-loweri.jpg\" data-src=\"https:\/\/scx2.b-cdn.net\/gfx\/news\/2025\/certain-glucose-loweri.jpg\" data-sub-html=\"\">\n<figure class=\"article-img\">\n<\/figure><\/div>\n<\/div>\n<p>Pour les patients atteints de diab\u00e8te de type 2 (T2D) et de trouble pulmonaire obstructif chronique (CPOC), les inhibiteurs du cotransporteur-2 de sodium-glucose (SGLT-2IS) et les agonistes des r\u00e9cepteurs du peptide-1 de type glucagon (GLP-1 RAS) sont associ\u00e9s \u00e0 une r\u00e9duction des agonistes des r\u00e9cepteurs du peptide-1 (GLP-1) r\u00e9duits \u00e0 une r\u00e9duction du peptide-1 (GLP-1 RAS) Risque d&rsquo;exacerbations mod\u00e9r\u00e9es ou s\u00e9v\u00e8res de MPOC par rapport aux inhibiteurs de la dipeptidyl peptidase 4 (DPP-4IS), selon une \u00e9tude publi\u00e9e en ligne le 10 f\u00e9vrier <i>M\u00e9decine interne JAMA<\/i>.<\/p>\n<p>Avik Ray, MD, from Brigham and Women&rsquo;s Hospital and Harvard Medical School in Boston, and colleagues conducted a comparative effectiveness study to assess the risk for moderate or severe COPD exacerbations among patients aged 40 years or older with T2D and active COPD who initiated treatment with SGLT-2IS contre DPP-4IS; GLP-1 RAS contre DPP-4IS; et SGLT-2IS contre GLP-1 RAS (27 991; 32 107; et 36 218 paires, respectivement).<\/p>\n<p>The researchers found that the risk for moderate or severe COPD exacerbation was lower among those treated with SGLT-2is versus DPP-4is and among those treated with GLP-1 RAs versus DPP-4is (9.26 versus 11.4 per 100 person-years (hazard ratio , 0,81) et 9,89 contre 11,49 pour 100 ann\u00e9es-personnes (rapport de risque, 0,86), respectivement), avec des diff\u00e9rences minimales observ\u00e9 parmi ceux trait\u00e9s avec SGLT-2IS par rapport aux Ras GLP-1. \u00c0 travers la sensibilit\u00e9 et les analyses de sous-groupes, les r\u00e9sultats \u00e9taient coh\u00e9rents.<\/p>\n<p>\u00ab\u00a0Ces r\u00e9sultats sugg\u00e8rent que SGLT-2IS et GLP-1 RAS peuvent \u00eatre pr\u00e9f\u00e9rables \u00e0 DPP4IS lors de la d\u00e9cision des m\u00e9dicaments hypotesqueux pour les patients atteints de T2D et de MPOC active\u00a0\u00bb, \u00e9crivent les auteurs. \u00ab\u00a0Cependant, \u00e9tant donn\u00e9 la nature observationnelle de l&rsquo;\u00e9tude, il existe un potentiel de confusion r\u00e9siduelle ou non mesur\u00e9e, et les r\u00e9sultats d&rsquo;\u00e9tudes cliniques et d&rsquo;essais cliniques similaires aideront \u00e0 corroborer ces r\u00e9sultats.\u00a0\u00bb<\/p>\n<p>Plusieurs auteurs ont r\u00e9v\u00e9l\u00e9 des liens avec l&rsquo;industrie pharmaceutique; Un auteur a r\u00e9v\u00e9l\u00e9 \u00eatre un t\u00e9moin expert en litige contre les fabricants d&rsquo;inhalateurs.<\/p>\n<p>                                        <!-- print only --><\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Pour les patients atteints de diab\u00e8te de type 2 (T2D) et de trouble pulmonaire obstructif<\/p>\n","protected":false},"author":1,"featured_media":4515,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[86],"tags":[3747,2791,4164,425,4163,87,4165,40],"class_list":["post-4514","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-les-maladies","tag-associes","tag-certains","tag-dexacerbations","tag-faible","tag-hypothecaires","tag-medicaments","tag-mpoc","tag-risque","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-50","resize-featured-image"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Certains m\u00e9dicaments hypoth\u00e9caires associ\u00e9s \u00e0 un risque plus faible d&#039;exacerbations de la MPOC - RVH-Synergie.org<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Certains m\u00e9dicaments hypoth\u00e9caires associ\u00e9s \u00e0 un risque plus faible d&#039;exacerbations de la MPOC - RVH-Synergie.org\" \/>\n<meta property=\"og:description\" content=\"Pour les patients atteints de diab\u00e8te de type 2 (T2D) et de trouble pulmonaire obstructif\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/\" \/>\n<meta property=\"og:site_name\" content=\"RVH-Synergie\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-21T20:56:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-21T20:56:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/02\/1740171399_Certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"773\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Charles Martinez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Charles Martinez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/\"},\"author\":{\"name\":\"Charles Martinez\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\"},\"headline\":\"Certains m\u00e9dicaments hypoth\u00e9caires associ\u00e9s \u00e0 un risque plus faible d&rsquo;exacerbations de la MPOC\",\"datePublished\":\"2025-02-21T20:56:38+00:00\",\"dateModified\":\"2025-02-21T20:56:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/\"},\"wordCount\":369,\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/02\/1740171399_Certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations.jpg\",\"keywords\":[\"associ\u00e9s\",\"certains\",\"dexacerbations\",\"faible\",\"hypoth\u00e9caires\",\"m\u00e9dicaments\",\"MPOC\",\"risque\"],\"articleSection\":[\"Les maladies\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/\",\"name\":\"Certains m\u00e9dicaments hypoth\u00e9caires associ\u00e9s \u00e0 un risque plus faible d'exacerbations de la MPOC - RVH-Synergie.org\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/02\/1740171399_Certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations.jpg\",\"datePublished\":\"2025-02-21T20:56:38+00:00\",\"dateModified\":\"2025-02-21T20:56:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/#primaryimage\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/02\/1740171399_Certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/02\/1740171399_Certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations.jpg\",\"width\":1280,\"height\":773,\"caption\":\"Certains m\u00e9dicaments hypoth\u00e9caires associ\u00e9s \u00e0 un risque plus faible d'exacerbations de la MPOC\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/rvh-synergie.org\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Certains m\u00e9dicaments hypoth\u00e9caires associ\u00e9s \u00e0 un risque plus faible d&rsquo;exacerbations de la MPOC\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"name\":\"RVH-Synergie.org\",\"description\":\"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.\",\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\",\"name\":\"RVH-Synergie.org\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"width\":512,\"height\":512,\"caption\":\"RVH-Synergie.org\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\",\"name\":\"Charles Martinez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"caption\":\"Charles Martinez\"},\"description\":\"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.\",\"sameAs\":[\"https:\/\/rvh-synergie.org\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Certains m\u00e9dicaments hypoth\u00e9caires associ\u00e9s \u00e0 un risque plus faible d'exacerbations de la MPOC - RVH-Synergie.org","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/","og_locale":"fr_FR","og_type":"article","og_title":"Certains m\u00e9dicaments hypoth\u00e9caires associ\u00e9s \u00e0 un risque plus faible d'exacerbations de la MPOC - RVH-Synergie.org","og_description":"Pour les patients atteints de diab\u00e8te de type 2 (T2D) et de trouble pulmonaire obstructif","og_url":"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/","og_site_name":"RVH-Synergie","article_published_time":"2025-02-21T20:56:38+00:00","article_modified_time":"2025-02-21T20:56:39+00:00","og_image":[{"width":1280,"height":773,"url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/02\/1740171399_Certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations.jpg","type":"image\/jpeg"}],"author":"Charles Martinez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Charles Martinez","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/#article","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/"},"author":{"name":"Charles Martinez","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560"},"headline":"Certains m\u00e9dicaments hypoth\u00e9caires associ\u00e9s \u00e0 un risque plus faible d&rsquo;exacerbations de la MPOC","datePublished":"2025-02-21T20:56:38+00:00","dateModified":"2025-02-21T20:56:39+00:00","mainEntityOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/"},"wordCount":369,"publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/02\/1740171399_Certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations.jpg","keywords":["associ\u00e9s","certains","dexacerbations","faible","hypoth\u00e9caires","m\u00e9dicaments","MPOC","risque"],"articleSection":["Les maladies"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/","url":"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/","name":"Certains m\u00e9dicaments hypoth\u00e9caires associ\u00e9s \u00e0 un risque plus faible d'exacerbations de la MPOC - RVH-Synergie.org","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#website"},"primaryImageOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/#primaryimage"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/02\/1740171399_Certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations.jpg","datePublished":"2025-02-21T20:56:38+00:00","dateModified":"2025-02-21T20:56:39+00:00","breadcrumb":{"@id":"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/#primaryimage","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/02\/1740171399_Certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/02\/1740171399_Certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations.jpg","width":1280,"height":773,"caption":"Certains m\u00e9dicaments hypoth\u00e9caires associ\u00e9s \u00e0 un risque plus faible d'exacerbations de la MPOC"},{"@type":"BreadcrumbList","@id":"https:\/\/rvh-synergie.org\/actualites\/certains-medicaments-hypothecaires-associes-a-un-risque-plus-faible-dexacerbations-de-la-mpoc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/rvh-synergie.org\/actualites\/"},{"@type":"ListItem","position":2,"name":"Certains m\u00e9dicaments hypoth\u00e9caires associ\u00e9s \u00e0 un risque plus faible d&rsquo;exacerbations de la MPOC"}]},{"@type":"WebSite","@id":"https:\/\/rvh-synergie.org\/actualites\/#website","url":"https:\/\/rvh-synergie.org\/actualites\/","name":"RVH-Synergie.org","description":"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.","publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/rvh-synergie.org\/actualites\/#organization","name":"RVH-Synergie.org","url":"https:\/\/rvh-synergie.org\/actualites\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","width":512,"height":512,"caption":"RVH-Synergie.org"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560","name":"Charles Martinez","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","caption":"Charles Martinez"},"description":"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.","sameAs":["https:\/\/rvh-synergie.org\/"]}]}},"_links":{"self":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/4514","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/comments?post=4514"}],"version-history":[{"count":0,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/4514\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media\/4515"}],"wp:attachment":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media?parent=4514"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/categories?post=4514"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/tags?post=4514"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}